How to Evaluate "GLP-1 Gummy" Claims Responsibly Consumers should distinguish between (1) prescription GLP-1 receptor agonists, which have extensive clinical trial evidence, and (2) dietary supplements that cite ingredient research but typically lack finished-product trials
In the comparison of oral semaglutide with dulaglutide, the largest increase in the ICER was observed when applying only differences in treatment effects that were statistically significant in the NMA, where the only difference between the treatment arms was the change in BMI
Both agents may exert favourable cardiovascular effects
But when your skin becomes dry, or you develop skin conditions like psoriasis or eczema, the natural barrier becomes weakened
CONCLUSIONS GLP-1 RAs and multi-agonist therapies combining GLP-1 with GIP and/or GCG agonism embody transformative therapeutic approaches for MASLD/MASH, addressing multiple pathogenic pathways through complementary mechanisms of action